RENALYTIX PLC Logo

RENALYTIX PLC

Develops AI-enabled diagnostic solutions for the clinical management of kidney disease.

RENX | IL

Overview

Corporate Details

ISIN(s):
GB00BYWL4Y04 (+1 more)
LEI:
213800NTOH3FK3WER551
Country:
United Kingdom
Address:
2 LEMAN STREET, E1W 9US LONDON

Description

Renalytix is a diagnostics company that develops artificial intelligence-enabled solutions for the clinical management of kidney disease. Its flagship product, KidneyIntelX.dkd™, is an FDA-authorized blood test for adults with type 2 diabetes and early-stage chronic kidney disease. The test utilizes a proprietary bioprognostic™ methodology to analyze biomarkers and clinical data, predicting the risk of a progressive decline in kidney function over a five-year period. This risk assessment enables clinicians to identify high-risk patients and implement targeted, guideline-recommended treatments to slow disease progression and improve outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-19 13:30
Holding(s) in Company
English 49.8 KB
2025-12-17 14:55
Holding(s) in Company
English 49.8 KB
2025-12-16 15:05
Holding(s) in Company
English 49.8 KB
2025-12-09 12:10
Result of AGM
English 33.5 KB
2025-12-09 08:20
AGM Statement
English 20.0 KB
2025-11-27 15:50
Holding(s) in Company
English 49.8 KB
2025-11-25 16:55
Holding(s) in Company
English 50.2 KB
2025-11-25 08:25
Plan to Implement ADS Ratio Change
English 18.4 KB
2025-11-12 08:30
Pivotal kidneyintelX.dkd data published
English 27.0 KB
2025-11-05 17:15
Holding(s) in Company
English 49.8 KB
2025-11-04 19:15
Publication of Annual Report & Notice of AGM
English 16.4 KB
2025-11-03 13:20
Holding(s) in Company
English 49.8 KB
2025-11-03 08:25
Audited Full Year Fiscal 2025 Results
English 615.2 KB
2025-10-30 17:58
Holding(s) in Company
English 51.4 KB
2025-10-28 17:04
Holding(s) in Company
English 51.4 KB

Automate Your Workflow. Get a real-time feed of all RENALYTIX PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RENALYTIX PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RENALYTIX PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Uses an AI platform for rare disease diagnosis and continuous data reanalysis.
South Korea
394800
AdaptHealth Corp. Logo
Provider of home medical equipment, supplies, and related healthcare-at-home solutions.
United States of America
AHCO
Addus HomeCare Corp Logo
Provider of in-home personal care, home health, and hospice services.
United States of America
ADUS
ADICON Holdings Limited Logo
Provider of independent clinical laboratory services for hospitals and health centers.
China
9860
Aimei Health Technology Co., Ltd. Logo
A special purpose acquisition company (SPAC) focused on the healthcare sector.
United States of America
AFJK
Allcore Logo
Holding company providing consulting services for small and medium-sized enterprises.
Italy
CORE
ALLURION TECHNOLOGIES, INC. Logo
Offers a weight-loss platform featuring a procedure-less, swallowable gastric balloon.
United States of America
ALUR
Artra Group Corporation Logo
Provides start-up and management support for healthcare therapy clinics.
Japan
6029
Aveanna Healthcare Holdings, Inc. Logo
A diversified home care platform providing healthcare for medically complex patients.
United States of America
AVAH
Bastide Le Confort Médical Logo
Provides medical equipment and services for home care and healthcare professionals.
France
BLC

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.